|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 28, 2004
Pharmadigm Closes $3 Million Series B Financing. Pharmadigm Changes Corporate
Name to Inflabloc Pharmaceuticals, Inc.
February 9, 2006
Inflabloc Pharmaceuticals, Inc. Closes $6 Million Series C Financing and
Merger with Manticore Pharmaceuticals, Inc.
 |
 |
|
 |
|
|
